Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.

Douros A, Dell'Aniello S, Dehghan G, Boivin JF, Renoux C.

Neurology. 2019 Sep 3;93(10):e1010-e1020. doi: 10.1212/WNL.0000000000008060. Epub 2019 Aug 7.

PMID:
31391245
2.

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes.

Abrahami D, Douros A, Yin H, Yu OHY, Azoulay L.

Diabetes Care. 2019 Sep;42(9):e150-e152. doi: 10.2337/dc19-0849. Epub 2019 Jul 11. No abstract available.

PMID:
31296645
3.

Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.

Filion KB, Douros A, Azoulay L, Yin H, Yu OH, Suissa S.

Br J Clin Pharmacol. 2019 Jul 5. doi: 10.1111/bcp.14056. [Epub ahead of print]

PMID:
31276600
4.

Opioids and the Risk of Infection: A Critical Appraisal of the Pharmacologic and Clinical Evidence.

Khosrow-Khavar F, Kurteva S, Cui Y, Filion KB, Douros A.

Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):565-575. doi: 10.1080/17425255.2019.1634053. Epub 2019 Jun 27. Review.

PMID:
31211608
5.

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes.

Douros A, Rouette J, Yin H, Yu OHY, Filion KB, Azoulay L.

Diabetes Care. 2019 Aug;42(8):1496-1503. doi: 10.2337/dc19-0409. Epub 2019 Jun 10.

PMID:
31182489
6.

Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies.

Douros A, Durand M, Doyle CM, Yoon S, Reynier P, Filion KB.

Drug Saf. 2019 Oct;42(10):1135-1148. doi: 10.1007/s40264-019-00842-1. Review.

PMID:
31175610
7.

Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer.

Kreutz R, Algharably EAH, Douros A.

J Hypertens. 2019 Oct;37(10):1950-1958. doi: 10.1097/HJH.0000000000002136.

PMID:
31145177
8.

Re: Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.

Khosrow-Khavar F, Kurteva S, Douros A.

J Natl Cancer Inst. 2019 Apr 24. pii: djz066. doi: 10.1093/jnci/djz066. [Epub ahead of print] No abstract available.

PMID:
31020327
9.

Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study.

Douros A, Tölle M, Ebert N, Gaedeke J, Huscher D, Kreutz R, Kuhlmann MK, Martus P, Mielke N, Schneider A, Schuchardt M, van der Giet M, Schaeffner E.

Eur Heart J. 2019 Jul 1;40(25):2021-2028. doi: 10.1093/eurheartj/ehz071.

PMID:
30805599
10.

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.

Douros A, Renoux C, Yin H, Filion KB, Suissa S, Azoulay L.

Am J Med. 2019 Feb;132(2):191-199.e12. doi: 10.1016/j.amjmed.2018.10.008. Epub 2018 Oct 25.

PMID:
30691551
11.

What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.

Sommet A, Bénévent J, Rousseau V, Chebane L, Douros A, Montastruc JL, Montastruc F.

J Gen Intern Med. 2019 Apr;34(4):502-503. doi: 10.1007/s11606-018-4774-2. No abstract available.

PMID:
30565153
12.

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OH, Faillie JL, Montastruc F, Platt RW, Bouganim N, Azoulay L.

BMJ. 2018 Dec 5;363:k4880. doi: 10.1136/bmj.k4880.

13.

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L.

Diabetes Care. 2018 Nov;41(11):2330-2338. doi: 10.2337/dc17-2280. Epub 2018 Aug 27.

PMID:
30150234
14.

Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L.

Epidemiology. 2018 Nov;29(6):904-912. doi: 10.1097/EDE.0000000000000891.

PMID:
30028343
15.

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S.

BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693.

16.

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, Azoulay L.

BMJ. 2018 Mar 21;360:k872. doi: 10.1136/bmj.k872.

17.

Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review.

Douros A, Ades M, Renoux C.

CNS Drugs. 2018 Apr;32(4):321-334. doi: 10.1007/s40263-018-0507-7.

PMID:
29536379
18.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

19.
20.

Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study
.

Douros A, Bronder E, Klimpel A, Erley C, Garbe E, Kreutz R.

Clin Nephrol. 2018 Jan;89 (2018)(1):18-26. doi: 10.5414/CN109212.

PMID:
29035197
21.

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.

Douros A, Renoux C, Coulombe J, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1546-1554. doi: 10.1002/pds.4333. Epub 2017 Oct 6.

PMID:
28984052
22.

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S.

Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1.

PMID:
28864502
23.

Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.

Kreutz R, Scholze J, Douros A.

Curr Vasc Pharmacol. 2018 Jan 26;16(2):197-203. doi: 10.2174/1570161115666170821155555.

PMID:
28828980
24.

Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Bolbrinker J, Garbe E, Douros A, Huber M, Bronder E, Klimpel A, Andersohn F, Meyer O, Salama A, Kreutz R.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1149-1155. doi: 10.1002/pds.4235. Epub 2017 May 24.

PMID:
28544026
25.

Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System.

Flaig T, Douros A, Bronder E, Klimpel A, Kreutz R, Garbe E.

J Clin Pharm Ther. 2016 Dec;41(6):718-721. doi: 10.1111/jcpt.12456. Epub 2016 Sep 27.

PMID:
27670839
26.

[Pharmacovigilance in Germany : It is about time].

Douros A, Schaefer C, Kreutz R, Garbe E.

Internist (Berl). 2016 Jun;57(6):616-23. doi: 10.1007/s00108-016-0068-0. Review. German.

PMID:
27224991
27.

Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions.

Douros A, Jobski K, Kollhorst B, Schink T, Garbe E.

Br J Clin Pharmacol. 2016 Sep;82(3):839-48. doi: 10.1111/bcp.13019. Epub 2016 Jun 22.

28.

Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J.

Int J Mol Sci. 2016 Jan 15;17(1). pii: E114. doi: 10.3390/ijms17010114.

29.

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

Douros A, Grabowski K, Stahlmann R.

Expert Opin Drug Metab Toxicol. 2015;11(12):1849-59. doi: 10.1517/17425255.2015.1098617. Epub 2015 Oct 12. Review. Erratum in: Expert Opin Drug Metab Toxicol. 2015;11(12):v.

PMID:
26457865
30.

Estimating kidney function and use of oral antidiabetic drugs in elderly.

Douros A, Ebert N, Jakob O, Martus P, Kreutz R, Schaeffner E.

Fundam Clin Pharmacol. 2015 Jun;29(3):321-8. doi: 10.1111/fcp.12118. Epub 2015 Apr 17.

PMID:
25817734
31.

Erratum to: flupirtine-induced liver injury--seven cases from the Berlin Case-Control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E.

Eur J Clin Pharmacol. 2015 Mar;71(3):387. doi: 10.1007/s00228-015-1810-6. No abstract available.

PMID:
25604511
32.

Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Sarganas G, Kreutz R, Garbe E.

Br J Clin Pharmacol. 2015 Jun;79(6):988-99. doi: 10.1111/bcp.12565.

33.

Safety issues and drug-drug interactions with commonly used quinolones.

Douros A, Grabowski K, Stahlmann R.

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25-39. doi: 10.1517/17425255.2014.970166. Epub 2014 Nov 26. Review.

PMID:
25423877
34.

Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome.

Douros A, Schlemm L, Bolbrinker J, Ebinger M, Kreutz R.

Thromb Haemost. 2014 Aug;112(2):419-20. doi: 10.1160/TH14-02-0104. Epub 2014 Apr 3. No abstract available.

PMID:
24695752
35.

Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E.

Eur J Clin Pharmacol. 2014 Apr;70(4):453-9. doi: 10.1007/s00228-013-1631-4. Epub 2013 Dec 24. Erratum in: Eur J Clin Pharmacol. 2015 Mar;71(3):387.

PMID:
24366502
36.

Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases.

Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Ockenga J, Kreutz R, Garbe E.

Aliment Pharmacol Ther. 2013 Oct;38(7):825-34. doi: 10.1111/apt.12461. Epub 2013 Aug 19.

37.

Ramipril-induced liver injury: case report and review of the literature.

Douros A, Kauffmann W, Bronder E, Klimpel A, Garbe E, Kreutz R.

Am J Hypertens. 2013 Sep;26(9):1070-5. doi: 10.1093/ajh/hpt090. Epub 2013 Jun 8. Review.

PMID:
23747952
38.

[Mortality and morbidity of small premature infants (<1,500 g) in relation to presentation and delivery mode].

Feige A, Douros A.

Z Geburtshilfe Neonatol. 1996 Mar-Apr;200(2):50-5. German.

PMID:
8767287

Supplemental Content

Loading ...
Support Center